ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Biohaven Pharmaceuticals INC.

Official 2024 U.S. DOL Form 5500 summary for Biohaven Pharmaceuticals INC. (Biohaven Pharmaceuticals INC 401(k) Plan · EIN 46-4274360 · PN 001): $60.20M net assets, 251 active participants, and $23.73 per $10,000 (23.73 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorBiohaven Pharmaceuticals INC.
Filing IdentifierBiohaven Pharmaceuticals INC 401(k) Plan · EIN 46-4274360 · PN 001
Plan Category & State401(k) Defined Contribution (CT)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$60.20M
Active Participants251
Direct Admin Fee Rate$23.73 per $10,000 (23.73 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderCambridge Investment Research
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI